Brief: Dextech Medical Announces Positive Results From The Myeloma Study

Dextech Medical AB

23/01/2024 16:12

Jan 23 (Reuters) - Dextech Medical AB  DEXTECH.TE :
    * ANNOUNCES POSITIVE RESULTS FROM THE MYELOMA STUDY
    * BASELINE VALUE FOR CTX DECREASES BY ABOUT 80% AFTER 3
DOSES OF
OSTEODEX
    * STUDY IS EXPECTED TO BE COMPLETED IN Q4, 2024

Source text for Eikon:  ID:nWkr3HQK5W 
Further company coverage:  DEXTECH.TE 

 ((Reuters.Briefs@thomsonreuters.com;;))